Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Cost Platelet-Rich Plasma Injection for the Management of Hemarthropathy
NCT06543368Completed
- Sponsor
- University of Utah
- Start
- Jul 2024
- Primary completion
- May 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Open-label, single-arm trial of platelet-rich plasma in hemophilic arthropathy (HA), sponsored by University of Utah. Primary endpoint: Global Satisfaction (Numeric Rating System) at 6 months. Started Jul 2024; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
hemophilic arthropathy (HA)
Beyond the preview
Go deeper on NCT06543368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06543368.